It’s likely to be one of the biggest decisions you’ll have ever made, with the potential to shape your future career or even put you off research for life.

Genome sequencing has revolutionised biological sciences, allowing researchers to tackle completely new questions. But that doesn't mean there's universal access.

As part of its National Capability in Genomics and Single Cell Analysis, the Earlham Institute (EI) has established a state-of-the-art, multi-omic single-cell platform enabling genomic, epigenomic and transcriptomic analysis of individual cells from a wide variety of organisms.